Loading...

Ronald C Shank

Title(s)Professor Emeritus, Community and Environmental Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(949) 824-5186, 5436
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    GRADUATE TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGY
    NIH T32ES007157Jul 1, 1985 - Dec 31, 1996
    Role: Principal Investigator
    ENVIRONMENTAL HYDRAZINES AND METHYLATION OF DNA GUANINE
    NIH R01ES003726Jun 15, 1985 - Dec 31, 1993
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Safety Assessment of Trimellitic Anhydride Copolymers as Used in Cosmetics. Int J Toxicol. 2020 Nov/Dec; 39(3_suppl):74S-92S. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 33203270.
      View in: PubMed   Mentions:
    2. Safety Assessment of Monoglyceryl Monoesters as Used in Cosmetics. Int J Toxicol. 2020 Nov/Dec; 39(3_suppl):93S-126S. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 33203266.
      View in: PubMed   Mentions:
    3. Safety Assessment of Polyaminopropyl Biguanide (Polyhexamethylene Biguanide Hydrochloride) as Used in Cosmetics. Int J Toxicol. 2020 Nov/Dec; 39(3_suppl):26S-73S. Johnson W, Boyer I, Zhu J, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Heldreth B. PMID: 33203268.
      View in: PubMed   Mentions:
    4. Safety Assessment of Silk Protein Ingredients as Used in Cosmetics. Int J Toxicol. 2020 Nov/Dec; 39(3_suppl):127S-144S. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 33203267.
      View in: PubMed   Mentions:
    5. Safety Assessment of Ceramides as Used in Cosmetics. Int J Toxicol. 2020 Nov/Dec; 39(3_suppl):5S-25S. Burnett CL, Boyer IJ, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 33203269.
      View in: PubMed   Mentions:
    6. Safety Assessment of 2-Amino-3-Hydroxypyridine as Used in Cosmetics. Int J Toxicol. 2020 09; 39(2_suppl):91S-97S. Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 32975151.
      View in: PubMed   Mentions:
    7. Safety Assessment of Lecithin and Other Phosphoglycerides as Used in Cosmetics. Int J Toxicol. 2020 09; 39(2_suppl):5S-25S. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 32975152.
      View in: PubMed   Mentions:
    8. Safety Assessment of Polyene Group as Used in Cosmetics. Int J Toxicol. 2020 09; 39(2_suppl):59S-90S. Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 32975153.
      View in: PubMed   Mentions:
    9. Safety Assessment of PEGylated Alkyl Glycerides as Used in Cosmetics. Int J Toxicol. 2020 09; 39(2_suppl):26S-58S. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 32975154.
      View in: PubMed   Mentions:
    10. Amended Safety Assessment of Parabens as Used in Cosmetics. Int J Toxicol. 2020 Jul/Aug; 39(1_suppl):5S-97S. Cherian P, Zhu J, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Heldreth B. PMID: 32723119.
      View in: PubMed   Mentions:
    11. Safety Assessment of Glycerin as Used in Cosmetics. Int J Toxicol. 2019 Nov/Dec; 38(3_suppl):6S-22S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 31840548.
      View in: PubMed   Mentions:
    12. Safety Assessment of Camellia sinensis-Derived Ingredients As Used in Cosmetics. Int J Toxicol. 2019 Nov/Dec; 38(3_suppl):48S-70S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 31840549.
      View in: PubMed   Mentions:
    13. Safety Assessment of Avena sativa (Oat)-Derived Ingredients As Used in Cosmetics. Int J Toxicol. 2019 Nov/Dec; 38(3_suppl):23S-47S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 31840550.
      View in: PubMed   Mentions:
    14. Safety Assessment of PCA (2-Pyrrolidone-5-Carboxylic Acid) and Its Salts as Used in Cosmetics. Int J Toxicol. 2019 Sep/Oct; 38(2_suppl):5S-11S. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 31522652.
      View in: PubMed   Mentions:
    15. Safety Assessment of Alkyl Phosphates as Used in Cosmetics. Int J Toxicol. 2019 Sep/Oct; 38(2_suppl):12S-32S. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 31522649.
      View in: PubMed   Mentions:
    16. Safety Assessment of Citrus-Derived Peel Oils as Used in Cosmetics. Int J Toxicol. 2019 Sep/Oct; 38(2_suppl):33S-59S. Burnett CL, Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 31522650.
      View in: PubMed   Mentions:
    17. Safety Assessment of Sorbitan Esters as Used in Cosmetics. Int J Toxicol. 2019 Sep/Oct; 38(2_suppl):60S-80S. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 31522651.
      View in: PubMed   Mentions:
    18. Safety Assessment of Fatty Acid Amidopropyl Dimethylamines as Used in Cosmetics. Int J Toxicol. 2019 May/Jun; 38(1_suppl):39S-69S. Burnett CL, Boyer I, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 31170841.
      View in: PubMed   Mentions:
    19. Safety Assessment of Monosaccharides, Disaccharides, and Related Ingredients as Used in Cosmetics. Int J Toxicol. 2019 May/Jun; 38(1_suppl):5S-38S. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 31170840.
      View in: PubMed   Mentions:
    20. Amended Safety Assessment of Methylisothiazolinone as Used in Cosmetics. Int J Toxicol. 2019 May/Jun; 38(1_suppl):70S-84S. Burnett CL, Boyer I, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 31170842.
      View in: PubMed   Mentions:
    21. Safety Assessment of Tocopherols and Tocotrienols as Used in Cosmetics. Int J Toxicol. 2018 Sep/Oct; 37(2_suppl):61S-94S. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA, Heldreth B. PMID: 30235959.
      View in: PubMed   Mentions:
    22. Safety Assessment of PEGs Cocamine and Related Ingredients as Used in Cosmetics. Int J Toxicol. 2018 Sep/Oct; 37(2_suppl):10S-60S. Boyer I, Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 30235961.
      View in: PubMed   Mentions:
    23. Safety Assessment of PEG-150 Pentaerythrityl Tetrastearate as Used in Cosmetics. Int J Toxicol. 2018 Sep/Oct; 37(2_suppl):5S-9S. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA, Heldreth B. PMID: 30235960.
      View in: PubMed   Mentions:
    24. Safety Assessment of Alkyl Betaines as Used in Cosmetics. Int J Toxicol. 2018 May/Jun; 37(1_suppl):28S-46S. Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA, Heldreth B. PMID: 29761731.
      View in: PubMed   Mentions:
    25. Safety Assessment of Polyether Lanolins as Used in Cosmetics. Int J Toxicol. 2018 May/Jun; 37(1_suppl):19S-27S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA, Heldreth B. PMID: 29761732.
      View in: PubMed   Mentions:
    26. Safety Assessment of Hydrolyzed Wheat Protein and Hydrolyzed Wheat Gluten as Used in Cosmetics. Int J Toxicol. 2018 May/Jun; 37(1_suppl):55S-66S. Burnett C, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA, Heldreth B. PMID: 29761728.
      View in: PubMed   Mentions:
    27. Safety Assessment of Magnesium Sulfate as Used in Cosmetics. Int J Toxicol. 2018 May/Jun; 37(1_suppl):47S-54S. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA, Heldreth B. PMID: 29761729.
      View in: PubMed   Mentions:
    28. Safety Assessment of Tromethamine, Aminomethyl Propanediol, and Aminoethyl Propanediol as Used in Cosmetics. Int J Toxicol. 2018 May/Jun; 37(1_suppl):5S-18S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. PMID: 29761730.
      View in: PubMed   Mentions:
    29. Safety Assessment of Plant-Derived Fatty Acid Oils. Int J Toxicol. 2017 Nov/Dec; 36(3_suppl):51S-129S. Burnett CL, Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F. PMID: 29243540.
      View in: PubMed   Mentions:
    30. Safety Assessment of Benzyl Alcohol, Benzoic Acid and its Salts, and Benzyl Benzoate. Int J Toxicol. 2017 Nov/Dec; 36(3_suppl):5S-30S. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 29243541.
      View in: PubMed   Mentions:
    31. Safety Assessment of Dimethiconol and Its Esters and Reaction Products as Used in Cosmetics. Int J Toxicol. 2017 Nov/Dec; 36(3_suppl):31S-50S. Johnson W, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 29243542.
      View in: PubMed   Mentions:
    32. Safety Assessment of Cross-Linked Alkyl Acrylates as Used in Cosmetics. Int J Toxicol. 2017 Sep/Oct; 36(5_suppl2):59S-88S. Fiume MM, Heldreth B, Boyer I, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 29025328.
      View in: PubMed   Mentions:
    33. Safety Assessment of Diethanolamine and Its Salts as Used in Cosmetics. Int J Toxicol. 2017 Sep/Oct; 36(5_suppl2):89S-110S. Fiume MM, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 29025348.
      View in: PubMed   Mentions:
    34. Amended Safety Assessment of Isethionate Salts as Used in Cosmetics. Int J Toxicol. 2017 May/Jun; 36(1_suppl):5S-16S. Burnett CL, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 28553736.
      View in: PubMed   Mentions:
    35. Safety Assessment of Amino Acid Alkyl Amides as Used in Cosmetics. Int J Toxicol. 2017 May/Jun; 36(1_suppl):17S-56S. Burnett CL, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 28553738.
      View in: PubMed   Mentions:
    36. Safety Assessment of Anthemis nobilis-Derived Ingredients as Used in Cosmetics. Int J Toxicol. 2017 May/Jun; 36(1_suppl):57S-66S. Johnson W, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 28553737.
      View in: PubMed   Mentions:
    37. Safety Assessment of Formic Acid and Sodium Formate as Used in Cosmetics. Int J Toxicol. 2016 11; 35(2 suppl):41S-54S. Johnson W, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 27913772.
      View in: PubMed   Mentions:
    38. Safety Assessment of Alumina and Aluminum Hydroxide as Used in Cosmetics. Int J Toxicol. 2016 11; 35(3 suppl):16S-33S. Becker LC, Boyer I, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 27913785.
      View in: PubMed   Mentions:
    39. Safety Assessment of Polyquaternium-22 and Polyquarternium-39 as Used in Cosmetics. Int J Toxicol. 2016 11; 35(3 suppl):47S-53S. Johnson W, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 27913787.
      View in: PubMed   Mentions:
    40. Safety Assessment of Achillea millefolium as Used in Cosmetics. Int J Toxicol. 2016 11; 35(3 suppl):5S-15S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 27913788.
      View in: PubMed   Mentions:
    41. Safety Assessment of Methyl Glucose Polyethers and Esters as Used in Cosmetics. Int J Toxicol. 2016 11; 35(2 suppl):12S-40S. Johnson W, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 27913771.
      View in: PubMed   Mentions:
    42. Safety Assessment of Dialkyl Sulfosuccinate Salts as Used in Cosmetics. Int J Toxicol. 2016 11; 35(3 suppl):34S-46S. Fiume MM, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 27913786.
      View in: PubMed   Mentions:
    43. Safety Assessment of Hydroxypropyl Bis(N-Hydroxyethyl-p-Phenylenediamine) HCl as Used in Cosmetics. Int J Toxicol. 2016 11; 35(2 suppl):5S-11S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 27488826.
      View in: PubMed   Mentions:
    44. Safety Assessment of Nitrocellulose and Collodion as Used in Cosmetics. Int J Toxicol. 2016 07; 35(1 Suppl):50S-9S. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 27383197.
      View in: PubMed   Mentions:
    45. Safety Assessment of Microbial Polysaccharide Gums as Used in Cosmetics. Int J Toxicol. 2016 07; 35(1 Suppl):5S-49S. Fiume MM, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 27383198.
      View in: PubMed   Mentions:
    46. Safety Assessment of Alkyl PEG/PPG Ethers as Used in Cosmetics. Int J Toxicol. 2016 07; 35(1 Suppl):60S-89S. Fiume MM, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 27383199.
      View in: PubMed   Mentions:
    47. Safety Assessment of Synthetic Fluorphlogopite as Used in Cosmetics. Int J Toxicol. 2015 Nov-Dec; 34(3 Suppl):43S-52S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 26684795.
      View in: PubMed   Mentions:
    48. Safety Assessment of Boron Nitride as Used in Cosmetics. Int J Toxicol. 2015 Nov-Dec; 34(3 Suppl):53S-60S. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 26684796.
      View in: PubMed   Mentions:
    49. Safety Assessment of Alkyl Ethylhexanoates as Used in Cosmetics. Int J Toxicol. 2015 Nov-Dec; 34(3 Suppl):61S-73S. Fiume M, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 26684798.
      View in: PubMed   Mentions:
    50. Safety Assessment of Panax spp Root-Derived Ingredients as Used in Cosmetics. Int J Toxicol. 2015 Nov-Dec; 34(3 Suppl):5S-42S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 26684797.
      View in: PubMed   Mentions:
    51. Safety Assessment of Ethanolamine and Ethanolamine Salts as Used in Cosmetics. Int J Toxicol. 2015 Sep; 34(2 Suppl):84S-98S. Fiume MM, Heldreth BA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 26362122.
      View in: PubMed   Mentions:
    52. Safety Assessment of Alkyl Esters as Used in Cosmetics. Int J Toxicol. 2015 Sep; 34(2 Suppl):5S-69S. Fiume MM, Heldreth BA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 26362120.
      View in: PubMed   Mentions:
    53. Safety Assessment of Alkyl PEG Sulfosuccinates as Used in Cosmetics. Int J Toxicol. 2015 Sep; 34(2 Suppl):70S-83S. Johnson W, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 26362121.
      View in: PubMed   Mentions:
    54. Safety Assessment of Pentaerythrityl Tetraesters as Used in Cosmetics. Int J Toxicol. 2015 Sep; 34(2 Suppl):99S-112S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 26362123.
      View in: PubMed   Mentions:
    55. Safety Assessment of Ethanolamides as Used in Cosmetics. Int J Toxicol. 2015 Jul-Aug; 34(1 Suppl):18S-34S. Fiume MM, Heldreth BA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 26227889.
      View in: PubMed   Mentions:
    56. Safety Assessment of Galactomannans as Used in Cosmetics. Int J Toxicol. 2015 Jul-Aug; 34(1 Suppl):35S-65S. Johnson W, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 26227890.
      View in: PubMed   Mentions:
    57. Safety Assessment of Dialkyl Malates as Used in Cosmetics. Int J Toxicol. 2015 Jul-Aug; 34(1 Suppl):5S-17S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 26227891.
      View in: PubMed   Mentions:
    58. Safety Assessment of Talc as Used in Cosmetics. Int J Toxicol. 2015 Jul-Aug; 34(1 Suppl):66S-129S. Fiume MM, Boyer I, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 26227892.
      View in: PubMed   Mentions:
    59. Safety assessment of Tin(IV) oxide as used in cosmetics. Int J Toxicol. 2014 Nov-Dec; 33(4 Suppl):40S-6S. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 25568164.
      View in: PubMed   Mentions:
    60. Safety assessment of nylon as used in cosmetics. Int J Toxicol. 2014 Nov-Dec; 33(4 Suppl):47S-60S. Burnett C, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 25568165.
      View in: PubMed   Mentions:
    61. Safety assessment of animal- and plant-derived amino acids as used in cosmetics. Int J Toxicol. 2014 Nov-Dec; 33(4 Suppl):5S-12S. Burnett C, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 25323218.
      View in: PubMed   Mentions:
    62. Safety assessment of Vitis vinifera (grape)-derived ingredients as used in cosmetics. Int J Toxicol. 2014 Sep-Oct; 33(3 Suppl):48S-83S. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 25297908.
      View in: PubMed   Mentions:
    63. Safety assessment of 6-hydroxyindole as used in cosmetics. Int J Toxicol. 2014 Sep-Oct; 33(3 Suppl):24S-35S. Burnett CL, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 25297906.
      View in: PubMed   Mentions:
    64. Safety assessment of modified terephthalate polymers as used in cosmetics. Int J Toxicol. 2014 Sep-Oct; 33(3 Suppl):36S-47S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 25297907.
      View in: PubMed   Mentions:
    65. Amended safety assessment of Hypericum perforatum-derived ingredients as used in cosmetics. Int J Toxicol. 2014 Sep-Oct; 33(3 Suppl):5S-23S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 25297909.
      View in: PubMed   Mentions:
    66. Safety Assessment of PEGylated oils as used in cosmetics. Int J Toxicol. 2014 Nov-Dec; 33(4 Suppl):13S-39S. Burnett CL, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 25163475.
      View in: PubMed   Mentions:
    67. Safety Assessment of Cucumis sativus (Cucumber)-Derived Ingredients as Used in Cosmetics. Int J Toxicol. 2014 05; 33(2 suppl):47S-64S. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 24861368.
      View in: PubMed   Mentions:
    68. Safety Assessment of Dimethicone Crosspolymers as Used in Cosmetics. Int J Toxicol. 2014 05; 33(2 suppl):65S-115S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 24861370.
      View in: PubMed   Mentions:
    69. Safety Assessment of Citric Acid, Inorganic Citrate Salts, and Alkyl Citrate Esters as Used in Cosmetics. Int J Toxicol. 2014 05; 33(2 suppl):16S-46S. Fiume MM, Heldreth BA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 24861367.
      View in: PubMed   Mentions:
    70. Safety Assessment of Chlorphenesin as Used in Cosmetics. Int J Toxicol. 2014 05; 33(2 suppl):5S-15S. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 24861369.
      View in: PubMed   Mentions:
    71. Safety assessment of ammonium hectorites as used in cosmetics. Int J Toxicol. 2013 Nov-Dec; 32(6 Suppl):33S-40S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 24335966.
      View in: PubMed   Mentions:
    72. Safety assessment of a-amino acids as used in cosmetics. Int J Toxicol. 2013 Nov-Dec; 32(6 Suppl):41S-64S. Burnett CL, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 24335967.
      View in: PubMed   Mentions:
    73. Amended safety assessment of formaldehyde and methylene glycol as used in cosmetics. Int J Toxicol. 2013 Nov-Dec; 32(6 Suppl):5S-32S. Boyer IJ, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 24335968.
      View in: PubMed   Mentions:
    74. Safety assessment of lauriminodipropionic acid, sodium lauriminodipropionate, and disodium lauriminodipropionate as used in cosmetics. Int J Toxicol. 2013 Sep-Oct; 32(5 Suppl):49S-55S. Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 24174473.
      View in: PubMed   Mentions:
    75. Safety assessment of bis-diglyceryl polyacyladipate-2 and bis-diglyceryl polyacyladipate-1 as used in cosmetics. Int J Toxicol. 2013 Sep-Oct; 32(5 Suppl):56S-64S. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 24174474.
      View in: PubMed   Mentions:
    76. Safety assessment of alkyl glyceryl ethers as used in cosmetics. Int J Toxicol. 2013 Sep-Oct; 32(5 Suppl):5S-21S. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 24174475.
      View in: PubMed   Mentions:
    77. Safety assessment of decyl glucoside and other alkyl glucosides as used in cosmetics. Int J Toxicol. 2013 Sep-Oct; 32(5 Suppl):22S-48S. Fiume MM, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 24174472.
      View in: PubMed   Mentions:
    78. Safety assessment of borosilicate glasses as used in cosmetics. Int J Toxicol. 2013 Sep-Oct; 32(5 Suppl):65S-72S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 24174476.
      View in: PubMed   Mentions:
    79. Safety assessment of 2-amino-4-hydroxyethylaminoanisole and 2-amino-4-hydroxyethylaminoanisole sulfate as used in cosmetics. Int J Toxicol. 2013 May-Jun; 32(3 Suppl):25S-35S. Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 23696576.
      View in: PubMed   Mentions:
    80. Safety assessment of diethanolamides as used in cosmetics. Int J Toxicol. 2013 May-Jun; 32(3 Suppl):36S-58S. Fiume MM, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 23696577.
      View in: PubMed   Mentions:
    81. Safety assessment of triethanolamine and triethanolamine-containing ingredients as used in cosmetics. Int J Toxicol. 2013 May-Jun; 32(3 Suppl):59S-83S. Fiume MM, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 23696578.
      View in: PubMed   Mentions:
    82. Safety assessment of silylates and surface-modified siloxysilicates. Int J Toxicol. 2013 May-Jun; 32(3 Suppl):5S-24S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 23696579.
      View in: PubMed   Mentions:
    83. Safety assessment of alkyl benzoates as used in cosmetics. Int J Toxicol. 2012 Nov-Dec; 31(6 Suppl):342S-72S. 'Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 23283706.
      View in: PubMed   Mentions:
    84. Safety assessment of isoparaffins as used in cosmetics. Int J Toxicol. 2012 Nov-Dec; 31(6 Suppl):269S-95S. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 23283704.
      View in: PubMed   Mentions:
    85. Safety assessment of trimoniums as used in cosmetics. Int J Toxicol. 2012 Nov-Dec; 31(6 Suppl):296S-341S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 23283705.
      View in: PubMed   Mentions:
    86. Safety assessment of 1,2-glycols as used in cosmetics. Int J Toxicol. 2012 Sep-Oct; 31(5 Suppl):147S-68S. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 23064773.
      View in: PubMed   Mentions:
    87. Safety assessment of stearyl heptanoate and related stearyl alkanoates as used in cosmetics. Int J Toxicol. 2012 Sep-Oct; 31(5 Suppl):141S-6S. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 23064772.
      View in: PubMed   Mentions:
    88. Safety assessment of alkyl PEG ethers as used in cosmetics. Int J Toxicol. 2012 Sep-Oct; 31(5 Suppl):169S-244S. Fiume MM, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 23064774.
      View in: PubMed   Mentions:
    89. Safety assessment of propylene glycol, tripropylene glycol, and PPGs as used in cosmetics. Int J Toxicol. 2012 Sep-Oct; 31(5 Suppl):245S-60S. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 23064775.
      View in: PubMed   Mentions:
    90. Final report of the Cosmetic Ingredient Review Expert Panel on the safety assessment of cocamidopropyl betaine (CAPB). Int J Toxicol. 2012 Jul-Aug; 31(4 Suppl):77S-111S. Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 22869896.
      View in: PubMed   Mentions:
    91. Final report of the Cosmetic Ingredient Review Expert Panel on the safety assessment of methyl acetate. Int J Toxicol. 2012 Jul-Aug; 31(4 Suppl):112S-36S. Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 22869894.
      View in: PubMed   Mentions:
    92. Final report of the Cosmetic Ingredient Review Expert Panel on the safety assessment of dicarboxylic acids, salts, and esters. Int J Toxicol. 2012 Jul-Aug; 31(4 Suppl):5S-76S. Fiume MM, Heldreth B, Eldreth H, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 22869895.
      View in: PubMed   Mentions:
    93. Safety assessment of cyclomethicone, cyclotetrasiloxane, cyclopentasiloxane, cyclohexasiloxane, and cycloheptasiloxane. Int J Toxicol. 2011 Dec; 30(6 Suppl):149S-227S. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 22247236.
      View in: PubMed   Mentions:
    94. Safety assessment of xylene sulfonic acid, toluene sulfonic acid, and alkyl aryl sulfonate hydrotropes as used in cosmetics. Int J Toxicol. 2011 Dec; 30(6 Suppl):270S-83S. Bergfeld WF, Belsito DV, Klaassen CD, Hill R, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 22247238.
      View in: PubMed   Mentions:
    95. Final report of the Cosmetic Ingredient Review Expert Panel on the safety assessment of pelargonic acid (nonanoic acid) and nonanoate esters. Int J Toxicol. 2011 Dec; 30(6 Suppl):228S-69S. Johnson W, Heldreth B, Bergfeld WF, Belsito DV, Klaassen CD, Hill R, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 22247237.
      View in: PubMed   Mentions:
    96. Final report of the Amended Safety Assessment of PVM/MA copolymer and its related salts and esters as used in cosmetics. Int J Toxicol. 2011 Oct; 30(5 Suppl):128S-44S. Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 22068629.
      View in: PubMed   Mentions:
    97. Amended safety assessment of Sesamum indicum (sesame) seed oil, hydrogenated sesame seed oil, Sesamum indicum (sesame) oil unsaponifiables, and sodium sesameseedate. Int J Toxicol. 2011 May; 30(3 Suppl):40S-53S. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 21772026.
      View in: PubMed   Mentions:
    98. Final report on the safety assessment of Cocos nucifera (coconut) oil and related ingredients. Int J Toxicol. 2011 May; 30(3 Suppl):5S-16S. Burnett CL, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 21772024.
      View in: PubMed   Mentions:
    99. Final report of the safety assessment of cosmetic ingredients derived from Zea mays (corn). Int J Toxicol. 2011 May; 30(3 Suppl):17S-39S. Andersen FA, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW. PMID: 21772025.
      View in: PubMed   Mentions:
    100. Final report of the Cosmetic Ingredient Review Expert Panel safety assessment of polymethyl methacrylate (PMMA), methyl methacrylate crosspolymer, and methyl methacrylate/glycol dimethacrylate crosspolymer. Int J Toxicol. 2011 May; 30(3 Suppl):54S-65S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 21772027.
      View in: PubMed   Mentions:
    101. Final report of the safety assessment of Kojic acid as used in cosmetics. Int J Toxicol. 2010 Nov-Dec; 29(6 Suppl):244S-73. Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 21164073.
      View in: PubMed   Mentions:
    102. Final report of the Cosmetic Ingredient Review Expert Panel amended safety assessment of Calendula officinalis-derived cosmetic ingredients. Int J Toxicol. 2010 Nov-Dec; 29(6 Suppl):221S-43. Andersen FA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW. PMID: 21164072.
      View in: PubMed   Mentions:
    103. Final amended safety assessment of hydroquinone as used in cosmetics. Int J Toxicol. 2010 Nov-Dec; 29(6 Suppl):274S-87. Andersen FA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW. PMID: 21164074.
      View in: PubMed   Mentions:
    104. Amended safety assessment of dodecylbenzenesulfonate, decylbenzenesulfonate, and tridecylbenzenesulfonate salts as used in cosmetics. Int J Toxicol. 2010 Nov-Dec; 29(6 Suppl):288S-305. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 21164075.
      View in: PubMed   Mentions:
    105. Final report of the amended safety assessment of myristic acid and its salts and esters as used in cosmetics. Int J Toxicol. 2010 Jul; 29(4 Suppl):162S-86S. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F. PMID: 20634506.
      View in: PubMed   Mentions:
    106. Final report of the amended safety assessment of sodium laureth sulfate and related salts of sulfated ethoxylated alcohols. Int J Toxicol. 2010 Jul; 29(4 Suppl):151S-61S. Robinson VC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F. PMID: 20634505.
      View in: PubMed   Mentions:
    107. Final report of the safety assessment of methylisothiazolinone. Int J Toxicol. 2010 Jul; 29(4 Suppl):187S-213S. Burnett CL, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F. PMID: 20634507.
      View in: PubMed   Mentions:
    108. Final safety assessment of thiodipropionic acid and its dialkyl esters as used in cosmetics. Int J Toxicol. 2010 Jul; 29(4 Suppl):137S-50S. Diamante C, Fiume MZ, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F. PMID: 20634504.
      View in: PubMed   Mentions:
    109. Final report on the safety assessment of sodium cetearyl sulfate and related alkyl sulfates as used in cosmetics. Int J Toxicol. 2010 May; 29(3 Suppl):115S-32S. Fiume M, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F. PMID: 20448271.
      View in: PubMed   Mentions:
    110. Final amended report of the safety assessment of toluene-2,5-diamine, toluene-2,5-diamine sulfate, and toluene-3,4-diamine as used in cosmetics. Int J Toxicol. 2010 May; 29(3 Suppl):61S-83S. Burnett CL, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F. PMID: 20448268.
      View in: PubMed   Mentions:
    111. Final report of the safety assessment of allantoin and its related complexes. Int J Toxicol. 2010 May; 29(3 Suppl):84S-97S. Becker LC, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F. PMID: 20448269.
      View in: PubMed   Mentions:
    112. Final report of the amended safety assessment of Quaternium-15 as used in cosmetics. Int J Toxicol. 2010 May; 29(3 Suppl):98S-114S. Becker LC, Bergfeld WF, Belsito DV, Klaassen CD, Hill R, Leibler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F. PMID: 20448270.
      View in: PubMed   Mentions:
    113. Final report on the safety assessment of Basic Violet 1, Basic Violet 3, and Basic Violet 4. Int J Toxicol. 2009 Nov-Dec; 28(6 Suppl 2):193S-204S. Diamante C, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F. PMID: 20086192.
      View in: PubMed   Mentions:
    114. Amended safety assessment of tall oil acid, sodium tallate, potassium tallate, and ammonium tallate. Int J Toxicol. 2009 Nov-Dec; 28(6 Suppl 2):252S-8S. Robinson V, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F. PMID: 20086195.
      View in: PubMed   Mentions:
    115. Final amended report on safety assessment on aminomethyl propanol and aminomethyl propanediol. Int J Toxicol. 2009 Nov-Dec; 28(6 Suppl):141S-61S. Burnett CL, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 19966147.
      View in: PubMed   Mentions:
    116. Final report on the safety assessment of PPG-2 methyl ether, PPG-3 methyl ether, and PPG-2 methyl ether acetate. Int J Toxicol. 2009 Nov-Dec; 28(6 Suppl):162S-74S. Robinson V, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 19966148.
      View in: PubMed   Mentions:
    117. Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract. Int J Toxicol. 2009 Nov-Dec; 28(6 Suppl):175S-88S. Robinson V, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 19966149.
      View in: PubMed   Mentions:
    118. Amended safety assessment of sodium picramate and picramic acid. Int J Toxicol. 2009 Nov-Dec; 28(6 Suppl 2):205S-16S. Becker LC, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F. PMID: 20086193.
      View in: PubMed   Mentions:
    119. Final report on the safety assessment of amino nitrophenols as used in hair dyes. Int J Toxicol. 2009 Nov-Dec; 28(6 Suppl 2):217S-51S. Burnett CL, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F. PMID: 20086194.
      View in: PubMed   Mentions:
    120. Final amended report on the safety assessment of Ammonium Thioglycolate, Butyl Thioglycolate, Calcium Thioglycolate, Ethanolamine Thioglycolate, Ethyl Thioglycolate, Glyceryl Thioglycolate, Isooctyl Thioglycolate, Isopropyl Thioglycolate, Magnesium Thioglycolate, Methyl Thioglycolate, Potassium Thioglycolate, Sodium Thioglycolate, and Thioglycolic Acid. Int J Toxicol. 2009 Jul-Aug; 28(4 Suppl):68-133. Burnett CL, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 19636068.
      View in: PubMed   Mentions:
    121. Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate. Int J Toxicol. 2009 Jul-Aug; 28(4 Suppl):5-67. Becker LC, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. PMID: 19636067.
      View in: PubMed   Mentions:
    122. Novel adenine adducts, N7-guanine-AFB1 adducts, and p53 mutations in patients with schistosomiasis and aflatoxin exposure. Cancer Detect Prev. 2006; 30(6):491-8. Habib SL, Said B, Awad AT, Mostafa MH, Shank RC. PMID: 17113242.
      View in: PubMed   Mentions:
    123. DNA-damaging effects of genotoxins in mixture: modulation of covalent binding to DNA. Toxicol Sci. 2000 Feb; 53(2):224-36. Ross MK, Said B, Shank RC. PMID: 10696770.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    124. DNA-damaging effects of genotoxins in mixture: nonadditive effects of aflatoxin B1 and N-acetylaminofluorene on their mutagenicity in Salmonella typhimurium. Toxicol Sci. 1999 Dec; 52(2):226-31. Said B, Ross MK, Hamade AK, Matsumoto DC, Shank RC. PMID: 10630575.
      View in: PubMed   Mentions: 1     Fields:    Translation:Cells
    125. Mutagenic activity and DNA adduct formation by 1, 2-epoxy-3-(p-nitrophenoxy)propane, an HIV-1 protease inhibitor and GST substrate. Biochem Biophys Res Commun. 1999 Aug 11; 261(3):844-7. Said B, Matsumoto DC, Hamade AK, Shank RC. PMID: 10441513.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    126. 5-Methylcytosine in CpG sites and the reactivity of nearest neighboring guanines toward the carcinogen aflatoxin B1-8,9-epoxide. Biochem Biophys Res Commun. 1999 Jan 08; 254(1):114-9. Ross MK, Mathison BH, Said B, Shank RC. PMID: 9920742.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    127. Initial levels of azoxymethane-induced DNA methyl adducts are not predictive of tumor susceptibility in inbred mice. Toxicol Appl Pharmacol. 1998 May; 150(1):196-203. Papanikolaou A, Shank RC, Delker DA, Povey A, Cooper DP, Rosenberg DW. PMID: 9630469.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    128. Changes in methyl-sensitive restriction sites of liver DNA from hamsters chronically exposed to hydrazine sulfate. Carcinogenesis. 1996 Dec; 17(12):2711-7. Zheng H, Shank RC. PMID: 9006110.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    129. Methylation status of DNA cytosine during the course of induction of liver cancer in hamsters by hydrazine sulfate. Carcinogenesis. 1996 Dec; 17(12):2703-9. FitzGerald BE, Shank RC. PMID: 9006109.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    130. Modulation of DNA adduct formation by successive exposures of DNA to small and bulky chemical carcinogens. Carcinogenesis. 1995 Dec; 16(12):3057-62. Said B, Ross MK, Salib T, Shank RC. PMID: 8603485.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    131. Hydralazine and other hydrazine derivatives and the formation of DNA adducts. Toxicol Appl Pharmacol. 1994 Jul; 127(1):91-8. Mathison BH, Murphy SE, Shank RC. PMID: 8048059.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    132. Hydrazine genotoxicity in the neonatal rat. Toxicol Appl Pharmacol. 1994 Jun; 126(2):295-300. Leakakos T, Shank RC. PMID: 8209382.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    133. Effect of 5-methylcytosine as a neighboring base on methylation of DNA guanine by N-methyl-N-nitrosourea. Carcinogenesis. 1993 Feb; 14(2):323-7. Mathison BH, Said B, Shank RC. PMID: 8435876.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    134. Formation and persistence of a DNA adduct in rodents treated with N-nitrosopyrrolidine. Carcinogenesis. 1991 Apr; 12(4):571-5. Hunt EJ, Shank RC. PMID: 2013122.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    135. Nearest neighbor effects on carcinogen binding to guanine runs in DNA. Nucleic Acids Res. 1991 Mar 25; 19(6):1311-6. Said B, Shank RC. PMID: 1903201.
      View in: PubMed   Mentions: 2     Fields:    Translation:Cells
    136. Role of formaldehyde hydrazone and catalase in hydrazine-induced methylation of DNA guanine. Carcinogenesis. 1988 Jan; 9(1):65-70. Lambert CE, Shank RC. PMID: 3335049.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    137. Methylation of DNA guanine during the course of induction of liver cancer in hamsters by hydrazine or dimethylnitrosamine. Carcinogenesis. 1987 Mar; 8(3):439-44. Bosan WS, Shank RC, MacEwen JD, Gaworski CL, Newberne PM. PMID: 3815739.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    138. Comparative study on the indirect methylation of liver DNA guanine by the 1-carbon pool in hepatotoxicity. Arch Toxicol Suppl. 1987; 10:204-16. Shank RC. PMID: 3472498.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    139. The role of formaldehyde in hydrazine-induced methylation of liver DNA guanine. Carcinogenesis. 1986 Mar; 7(3):413-8. Bosan WS, Lambert CE, Shank RC. PMID: 3948326.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    140. Tetraformyltrisazine and hydrazine-induced methylation of liver DNA guanine. Carcinogenesis. 1986 Mar; 7(3):419-22. Lambert CE, Bosan WS, Shank RC. PMID: 3948327.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    141. Kinetics of formation and persistence of ethylguanines in DNA of rats and hamsters treated with diethylnitrosamine. Cancer Res. 1985 May; 45(5):2076-84. Becker RA, Shank RC. PMID: 3986763.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    142. DNA ethylation in target and non-target organs of hamsters and rats treated with diethylnitrosamine. Cancer Lett. 1985 Feb; 26(1):17-24. Becker RA, Lu SS, Brésil H, Shank RC, Montesano R. PMID: 3971349.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    143. Toxicity-induced aberrant methylation of DNA and its repair. Pharmacol Rev. 1984 Jun; 36(2 Suppl):19S-24S. Shank RC. PMID: 6382354.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    144. Methylation of liver DNA guanine in hamsters given hydrazine. Toxicol Appl Pharmacol. 1983 Sep 15; 70(2):324-34. Bosan WS, Shank RC. PMID: 6623473.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    145. S-adenosylmethionine metabolism and DNA methylation in hydrazine-treated rats. Carcinogenesis. 1983 Aug; 4(8):953-7. Barrows LR, Shank RC, Magee PN. PMID: 6872153.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    146. Inhibitory effects of carbon tetrachloride on dimethylnitrosamine metabolism and DNA alkylation. Carcinogenesis. 1983; 4(5):537-9. Ruchirawat M, Mostafa MH, Shank RC, Weisburger EK. PMID: 6850983.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    147. Evidence for indirect genetic damage as methylation of DNA guanine in response to cytotoxicity. Dev Toxicol Environ Sci. 1983; 11:145-52. Shank RC. PMID: 6677451.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    148. Evidence for DNA adducts in rat liver after administration of N-nitrosopyrrolidine. Biochem Biophys Res Commun. 1982 Feb 26; 104(4):1343-8. Hunt EJ, Shank RC. PMID: 7073746.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    149. DNA methylation during chronic administration of 1,2-dimethylhydrazine in a carcinogenic regimen. Carcinogenesis. 1982; 3(8):857-60. Herron DC, Shank RC. PMID: 7127668.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    150. In vivo kinetics of O6-methylguanine and 7-methylguanine formation and persistence in DNA of rats treated with symmetrical dimethylhydrazine. Cancer Res. 1981 Oct; 41(10):3967-72. Herron DC, Shank RC. PMID: 7285005.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    151. Aberrant methylation of liver DNA in rats during hepatotoxicity. Toxicol Appl Pharmacol. 1981 Sep 15; 60(2):334-45. Barrows LR, Shank RC. PMID: 7281192.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    152. Methylation of liver DNA guanine in hydrazine hepatotoxicity: dose-response and kinetic characteristics of 7-methylguanine and O6-methylguanine formation and persistence in rats. Carcinogenesis. 1981; 2(11):1181-8. Becker RA, Barrows LR, Shank RC. PMID: 7318155.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    153. Methylated purines in human liver DNA after probable dimethylnitrosamine poisoning. Cancer Res. 1980 Sep; 40(9):3116-7. Herron DC, Shank RC. PMID: 7427930.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    154. Quantitative high-pressure liquid chromatographic analysis of methylated purines in DNA of rats treated with chemical carcinogens. Anal Biochem. 1979 Nov 15; 100(1):58-63. Herron DC, Shank RC. PMID: 543539.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    155. Oxidative metabolism of dimethylnitrosamine: correlation with toxicity. J Toxicol Environ Health. 1978 Jan; 4(1):161-72. Ruchirawat M, Shank RC. PMID: 633406.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    156. Metabolic activation of mycotoxins by animals and humans: an overview. J Toxicol Environ Health. 1977 Jul; 2(6):1229-44. Shank RC. PMID: 328914.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    157. Dose-response study of the carcinogenicity of dietary sodium nitrite and morpholine in rats and hamsters. Food Cosmet Toxicol. 1976 Jan; 14(1):1-8. Shank RC, Newberne PM. PMID: 176090.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    158. Effects of cytochalasin E on fluid balance in the rat. Toxicol Appl Pharmacol. 1975 Apr; 32(1):158-67. Glinsukon T, Shank RC, Wogan GN. PMID: 1135871.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    159. Acute and subacute toxicity of cytochalasin E in the rat. Toxicol Appl Pharmacol. 1975 Apr; 32(1):135-46. Glinsukon T, Shank RC, Wogan GN, Newberne PM. PMID: 1135869.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    160. Toxicology of N-nitroso compounds. Toxicol Appl Pharmacol. 1975 Mar; 31(3):361-8. Shank RC. PMID: 1096366.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    161. Formation of N-nitrosopyrrolidine in a dog's stomach. Br J Cancer. 1974 Sep; 30(3):279-83. Mysliwy TS, Wick EL, Archer MC, Shank RC, Newberne PM. PMID: 4451632.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    162. Induction of liver and lung tumours in rats by the simultaneous administration of sodium nitrite and morpholine. Food Cosmet Toxicol. 1973 Oct; 11(5):819-25. Ndwberne PM, Shank RC. PMID: 4358606.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    163. Acute toxicity of aflatoxin B 1 in the macaque monkey. Toxicol Appl Pharmacol. 1971 Oct; 20(2):227-31. Shank RC, Johnsen DO, Tanticharoenyos P, Wooding WL, Bourgeois CH. PMID: 5002435.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    164. Acute aflatoxin B1 toxicity in the macaque and its similarities to Reye's syndrome. Lab Invest. 1971 Mar; 24(3):206-16. Bourgeois CH, Shank RC, Grossman RA, Johnsen DO, Wooding WL, Chandavimol P. PMID: 4994463.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    165. Effect of dimethylnitrosamine on enzyme induction in rat liver. Biochem J. 1968 Jul; 108(4):625-31. Shank RC. PMID: 5667275.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    166. Similarities between the biochemical actions of cycasin and dimethylnitrosamine. Biochem J. 1967 Nov; 105(2):521-7. Shank RC, Magee PN. PMID: 5583994.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    167. Excretion and tissue distribution of radioactivity from aflatoxin B1-14-C in rats. Cancer Res. 1967 Oct; 27(10):1729-36. Wogan GN, Edwards GS, Shank RC. PMID: 6064951.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    Ronald's Networks
    Concepts (411)
    Derived automatically from this person's publications.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _